A potent reversible inhibitor of mitochondrial oxidative phosphorylation. FCCP is a useful tool for depolarizing mitochondrial membrane potential. Treatment of cells with FCCP at varying concentrations leads to partial (100 nM) or complete (10 µM) depolarization and apoptosis.
Product Specification
| Alternative Name: | Carbonylcyanide-4-(trifluoromethoxy)-phenylhydrazone |
| |
| Formula: | C10H5F3N4O |
| |
| MW: | 254.2 |
| |
| CAS: | 370-86-5 |
| |
| Purity: | ≥98% (HPLC) |
| |
| Identity: | Determined by 1H-NMR. |
| |
| Appearance: | Yellow solid. |
| |
| Solubility: | Soluble in DMSO |
| |
| Shipping: | Ambient |
| |
| Long Term Storage: | Ambient |
| |
| Regulatory Status: | RUO - Research Use Only |
| |
Please mouse over
Product Literature References
A selective inhibitor of mitofusin 1-βIIPKC association improves heart failure outcome in rats: J.C.B. Ferreira, et al.; Nat. Commun.
10, 329 (2019),
Abstract;
Full Text
A moderate but not total decrease of mitochondrial membrane potential triggers apoptosis in neuron-like cells: I. Gautier, et al.; Neuroreport
11, 2953 (2000),
Abstract;
Inositol 1,4,5-trisphosphate-induced Ca2+ release is inhibited by mitochondrial depolarization: T. J. Collins, et al.; Biochem. J.
347, 593 (2000),
Abstract;
Full Text
Staining of mitochondrial membranes with 10-nonyl acridine orange, MitoFluor Green, and MitoTracker Green is affected by mitochondrial membrane potential altering drugs: J. F. Keij, et al.; Cytometry
39, 203 (2000),
Abstract;
